methyl 1-(trifluoromethyl)isoquinoline-3-carboxylate
|
- $499.39 - $1379
- Product name: methyl 1-(trifluoromethyl)isoquinoline-3-carboxylate
- CAS: 1006707-71-6
- MF: C12H8F3NO2
- MW: 255.19
- EINECS:
- MDL Number:MFCD20921914
- Synonyms:methyl 1-(trifluoromethyl)isoquinoline-3-carboxylate;3-Isoquinolinecarboxylic acid, 1-(trifluoromethyl)-, methyl ester
4 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 5MG
- 250mg
- 1g
- ManufacturerAK Scientific
- Product number0246AA
- Product descriptionMethyl1-(trifluoromethyl)isoquinoline-3-carboxylate
- Packaging250mg
- Price$1379
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0369067
- Product descriptionMETHYL-1-(TRIFLUOROMETHYL)ISOQUINOLINE-3-CARBOXYLATE 95.00%
- Packaging5MG
- Price$499.39
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11368345
- Product descriptionMethyl1-(trifluoromethyl)isoquinoline-3-carboxylate 95+%
- Packaging1g
- Price$772
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number092553
- Product descriptionMethyl 1-(trifluoromethyl)isoquinoline-3-carboxylate 95+%
- Packaging250mg
- Price$985
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 0246AA | Methyl1-(trifluoromethyl)isoquinoline-3-carboxylate | 250mg | $1379 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | HCH0369067 | METHYL-1-(TRIFLUOROMETHYL)ISOQUINOLINE-3-CARBOXYLATE 95.00% | 5MG | $499.39 | 2021-12-16 | Buy |
| Crysdot | CD11368345 | Methyl1-(trifluoromethyl)isoquinoline-3-carboxylate 95+% | 1g | $772 | 2021-12-16 | Buy |
| Matrix Scientific | 092553 | Methyl 1-(trifluoromethyl)isoquinoline-3-carboxylate 95+% | 250mg | $985 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|